Choosing the Right Biotech Exit Strategy
Sep 24, 2019 - 42:15
Radio and PodcastLive Radio & PodcastsHealth
Knowing When to Call It Quits in Drug Development and Healthcare Innovations
The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence . To beat these odds, life sciences lea...
About This Episode
Knowing When to Call It Quits in Drug Development and Healthcare Innovations is an episode from BDO's Health & Life Sciences Rx Podcast by Olivia Clement. The drug development process is costly, time consuming and laden with risk—with only...
Podcast
This episode belongs to BDO's Health & Life Sciences Rx Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 22, 2020, 34:28 long, audio available.
Related Episodes
Continue listening to more episodes from BDO's Health & Life Sciences Rx Podcast.
Unleashing Nurse-Led Innovation
May 1, 2019 - 31:58
Adapting to Changing Market Winds: Healthcare REITS and Private Equity
Apr 10, 2019 - 37:06
Preparing for the Future of Elder Care
Mar 6, 2019 - 52:31
Global Conversations on Elder Care
Dec 13, 2018 - 30:15
Checking Healthcare's Pulse
Oct 8, 2018 - 23:22
Finding the Right Dose of Portfolio Risk
May 14, 2018 - 23:56
Adjusting to Disruption: The “New Normal” in Healthcare
Apr 18, 2018 - 67:36